Manufacturing Enterprise "Academpharm"  
220141 Minsk, Academician Kuprevich str. 5/3

The drug Memantine-NAN









Linked profile in other language
Natalia Safronova
+375 17 268 6364
The manufacturing enterprise "Academpharm" offers consumers the drug Memantine-NAN for the treatment of adult patients with Alzheimer's disease under a manufacturing agreement and is looking for partners to conclude a distribution services agreement.
International non-proprietary name: Memantine.
Pharmacological properties - There is evidence of the importance of disorders of glutamatergic transmission of impulses (especially in disorders of NMDA receptor neurotransmission) for the symptoms and progression of neurodegenerative dementia.

Memantine is a voltage-dependent, medium-affinity, non-competitive NMDA receptor antagonist that inhibits the effects of pathologically elevated glutamate levels, which can lead to the development of neuronal dysfunction.

The characteristics of the drug, instructions for patients and specialists can be found here (in Russian).
Advantages and Innovations
A drug for the treatment of adult patients with moderate to severe Alzheimer's disease.
Stage of development
Already on the market
Funding source
State budged
IPR status
Exclusive rights
Secret know-how
Sector group

Organization information

R&D institution
Year established
NACE keywords
C.21.10 - Manufacture of basic pharmaceutical products
C.21.20 - Manufacture of pharmaceutical preparations
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR)
Already engaged in transnational cooperation
Additional comments
ACADEMPHARM is a dynamically developing science-intensive state pharmaceutical enterprise.
- laboratory pharmaceutical research;
- industrial production of medicines and other pharmaceutical products, vitamin, vitamin-mineral and metabolic complexes, nutraceuticals;
- contract pharmaceutical production.

The state enterprise "AKADEMPHARM" has national certificates of GMP (good manufacturing practice) for the production of all forms of output of its own products.

The company has implemented and operates a pharmaceutical quality system developed in accordance with the requirements of national standards TKP 030-2017 (33050) "good manufacturing practice" and international requirements.

The pharmaceutical quality system includes good manufacturing practice, quality control and quality risk management, is fully documented and its effectiveness is monitored. All parts of the quality system are provided with competent personnel, a sufficient number of appropriate premises, equipment and facilities.

As part of the quality system, the enterprise has a quality assurance department and a quality control department, including:
- physical and chemical laboratory;
- microbiological laboratory;
- group of controllers.

The quality control department of the enterprise is accredited for compliance with GOST ISO / IEC 17025-2019.
Attestat_18.09.2020-pdf-min (2)

A multi-stage quality control system ensures incoming control of raw materials and materials, control of the production process and quality control of manufactured medicines.

Modern laboratory equipment, methods used, validation of quality control methods and production processes, as well as high professionalism of specialists guarantee the quality of products.

Further control of products is carried out during the entire shelf life of archival medicinal products of any series. Functioning system for drug safety monitoring and pharmacovigilance.

The state enterprise "AKADEMPHARM" guarantees the conformity of the manufactured products to their purpose and the requirements of registration documents, minimizing the risks for patients associated with the safety, quality and efficacy of manufactured medicines.
Languages spoken

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing Memantine-NAN for the treatment of adult patients with Alzheimer's disease under a manufacturing agreement.

Partners interested in purchasing Memantine-NAN for the treatment of adult patients with Alzheimer's disease under a distribution services agreement.
Type and size of partner sought
> 500
SME 51-250
SME 11-50
SME <= 10
R&D Institution


Views: 627
Statistics since 14.05.2023 16:28:01